A miracle drug for the rich? Europe must answer the Ozempic question

A retired Canadian woman working extra shifts as a substitute teacher to afford a medication that prevents diabetes is not the sort of story that usually sparks a geopolitical debate. Yet that is precisely what happened when Canada became the first G7 nation to approve generic versions of semaglutide, the active ingredient behind Ozempic and […]